2016
DOI: 10.1016/j.healun.2016.01.541
|View full text |Cite
|
Sign up to set email alerts
|

Diagnostic Value of Quantitative Tissue Markers (T2 Mapping and ECV) for Acute Cardiac Rejection Diagnosis: A Preliminary Experience

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2019
2019
2020
2020

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…CMR has been proposed as a noninvasive alternative. Recent studies have shown that a combination of T 2 mapping and ECV have the potential to be used as a surrogate biomarker for rejection . Additionally, ECV values are elevated in the myocardium of patients with multiple rejection episodes and may point to a poorer prognosis.…”
Section: Clinical Applicationsmentioning
confidence: 99%
“…CMR has been proposed as a noninvasive alternative. Recent studies have shown that a combination of T 2 mapping and ECV have the potential to be used as a surrogate biomarker for rejection . Additionally, ECV values are elevated in the myocardium of patients with multiple rejection episodes and may point to a poorer prognosis.…”
Section: Clinical Applicationsmentioning
confidence: 99%
“…myocardial oedema, 13,14 such as in acute allograft rejection. [15][16][17] This has been extensively studied in adult heart transplant patients, 9,15,18,19 but to date there is limited data on its application in the paediatric population.…”
mentioning
confidence: 99%